loxoprofen Patch 100 mg

A pharmaceutical manufacturer operating as an end-to-end CDMO/CMO partner for pharmaceutical products, with vertically integrated capabilities spanning active pharmaceutical ingredients, intermediates, and finished oral solid dosage forms such as tablets and capsules. The company highlights multiple cGMP-inspected manufacturing sites supporting both API and formulation supply, alongside strong in-house development and analytical support for scale-up and commercial production. Its quality system is described as fully GMP-driven across operations, with APIs having undergone EU-GMP inspection/certification and oral solid pharmaceutical products produced under Chinese GMP requirements, reinforced by a mature EHS and compliance culture to ensure reliable global supply.